Gemfibrozil Reduced the Risk for Coronary Events in Men With Coronary Artery Disease and Low Levels of High Density Lipoprotein Cholesterol
Evidence-Based Medicine - United Kingdom
doi 10.1136/ebm.5.2.49
Full Text
Open PDFAbstract
Available in full text
Categories
Date
March 1, 2000
Authors
Publisher
BMJ